Quantitative and Qualitative Malnutrition – Causes, Symptoms, and Clinical Consequences

Malnutrition represents a multifaceted pathophysiological condition characterized by chronic or acute deficiencies in essential macronutrients and micronutrients—including complete proteins, essential fatty acids, complex carbohydrates, fat-soluble and water-soluble vitamins, electrolytes, and trace elements. The cumulative effect of these deficiencies leads to progressive impairment of homeostatic regulatory mechanisms, resulting in metabolic dysfunction, compromised immune response, and tissue degradation. According to the latest guidelines from the European Society for Clinical Nutrition and Metabolism (ESPEN), a diagnosis of malnutrition requires meeting at least one of two primary criteria: (1) a body mass index (BMI) below the threshold of 18.5 kg/m² or (2) unintentional weight loss exceeding 10% regardless of the observation period or 5% over the preceding three months—while simultaneously considering age-specific BMI thresholds (20 kg/m² for individuals under 70 years of age and 22 kg/m² for those over 70) or a reduced fat-free mass index (FFMI < 15 kg/m² in women and < 17 kg/m² in men). Additional diagnostic indicators include decreased serum albumin levels (< 3.5 g/dL), clinical manifestations of nutritional dystrophy, and substantial weight loss (≥5% within one month or ≥10% over a 3–6 month period). Since 2012, mandatory nutritional screening for all hospitalized patients (excluding emergency admissions) has become standard practice, utilizing validated tools such as the Nutritional Risk Screening 2002 (NRS-2002) or the Subjective Global Assessment (SGA). Extended diagnostics may incorporate a comprehensive dietary history, anthropometric measurements, physical performance evaluations, and laboratory analyses of key biochemical parameters (including transferrin and prealbumin). Malnutrition is a worldwide concern affecting populations irrespective of age or geographic location, with particularly severe prevalence in regions experiencing economic downturns and social instability.

Malnutrition presents in three distinct clinical forms, classified according to the predominant nutrient deficiency. The first, known as kwashiorkor, is characterized by profound protein deficiency—particularly of the albumin fraction—as well as a marked decline in circulating lymphocyte counts, leading to impaired cellular immune responses. In advanced stages, peripheral edema and electrolyte imbalances emerge, yet fat reserves and muscle mass remain relatively preserved due to the rapid progression of this malnutrition type, which obscures weight loss in standard anthropometric measurements. The etiology of kwashiorkor remains incompletely understood, though leading hypotheses implicate oxidative stress (linked to insufficient dietary antioxidant intake) and intestinal dysbiosis, marked by an overgrowth of pathogenic *Fusobacterium* and *Proteobacteria* species at the expense of commensal colonic microbiota. These disturbances may persist for years even after clinical recovery. Treatment of kwashiorkor necessitates hospitalization, intensive dietary intervention tailored to the patient’s metabolic needs, and often adjunctive antibiotic therapy; untreated, the condition progresses to fatal metabolic acidosis. The second form, marasmus, manifests as a global decline in anthropometric indices and immunological parameters while serum protein levels remain normal. Its causes are well-documented—stemming from prolonged consumption of a calorie- and macronutrient-deficient diet as a consequence of chronic, uncomplicated starvation. An alternative trigger may be a prior bacterial infection. Clinical improvement is achievable through targeted high-nutrient enteral feeding. Mortality in marasmus is statistically lower than in kwashiorkor. The third and most common variant is mixed malnutrition, defined by concurrent deficits in both structural/functional proteins and adipose tissue, resulting from combined energy and protein substrate deficiencies or heightened catabolic states—such as those following trauma, surgery, or in the context of malignant diseases.

Malnutrition is intrinsically linked to the process of starvation, which manifests in two fundamentally distinct forms. The first, termed **simple starvation**, is categorized into a short-term phase (lasting fewer than 72 hours) and a long-term phase (extending beyond this threshold). In both scenarios, serum albumin concentrations remain initially unchanged, declining only during the advanced, terminal stage of energy deprivation. Concurrently, there is a progressive depletion of protein and fat reserves: the body first relies on glycogen stores as its primary energy source, but with prolonged starvation, it shifts to ketone body metabolism—critical for sustaining brain function and erythrocyte viability. The second form, designated **complicated starvation** (or stress starvation), arises as a consequence of severe illness or trauma. Its course is marked by a biphasic metabolic response: an initial reduction in metabolic rate, followed by a sharp increase driven by the surge of catabolic hormones (e.g., cortisol, glucagon). Additionally, there is significant pathological fluid and sodium retention, alongside profound disruptions in carbohydrate metabolism, which collectively amplify the risk of systemic complications.

Malnutrition induces a cascade of deleterious physiological alterations, including but not limited to: compromised immune competence, hematologic deficiencies (e.g., anemia), degradation of lean muscle mass coupled with diminished bone mineral density, impaired pulmonary and cardiac muscle performance, metabolic depression with concomitant hypothermia, electrolytic and fluid balance dysregulations, protracted wound healing, extended hospitalization durations, and escalated healthcare expenditures. High-risk populations encompass individuals with aberrant body mass indices (both underweight and obese), those with appetite disorders or food intolerances, geriatric patients, substance-dependent individuals (particularly alcoholics), post-gastrointestinal-resection patients, individuals with malabsorption syndromes, and those who have experienced >10% body weight loss within a six-month period. Untreated malnutrition may culminate in irreversible organ damage or fatal outcomes. Surgical candidates require mandatory pre- and postoperative nutritional support—preferably enteral, or parenteral in cases of gastrointestinal obstruction. Documented benefits of clinical nutrition therapy include: attenuation of physiological stress responses, diminished incidence of postoperative complications, accelerated functional recovery, reduced length of hospital stay, enhanced quality of care in surgical units, and overall cost containment in healthcare delivery.

The optimal nutritional management of malnourished individuals necessitates a multifaceted assessment of clinical variables, including the underlying etiology of nutrient deficiencies, symptom severity, comorbid conditions, and overall physical and psychological well-being. A cornerstone of therapeutic intervention lies in the **personalization of dietary regimens**, which must account not only for macronutrient and micronutrient requirements but also for sensory attributes—such as visual appeal, aroma, and texture—that can substantially enhance dietary adherence. Of particular significance is the integration of **medical nutrition therapy (MNT)**, including **foods for special medical purposes (FSMP)**, which may serve as either a supplemental or primary nutritional source for patients unable to meet their energy and protein needs through conventional oral intake. However, clinicians must remain vigilant for **refeeding syndrome**, a potentially fatal metabolic derangement characterized by severe electrolyte imbalances (hypophosphatemia, hypokalemia, hypomagnesemia) and vitamin deficiencies (primarily thiamine), which can precipitate multisystem organ dysfunction. Prophylactic measures involve a **gradual escalation of caloric intake** (initially 5–20 kcal/kg body weight) coupled with rigorous monitoring of biochemical markers, fluid balance, and acid-base homeostasis. A comprehensive treatment framework should further incorporate **lifestyle modifications**, such as **structured physical activity** (e.g., preprandial walks to stimulate appetite), **sleep hygiene optimization**, **stress mitigation techniques**, and—where indicated—**psychological counseling** to address underlying behavioral or emotional barriers to adequate nutrition.

Nutritional disorders represent a significant health challenge not only in regions characterized by low socioeconomic development but also in highly advanced societies with stable economic conditions. Chronic or acute deficiencies in essential micronutrients, macronutrients, vitamins, and proteins can lead to profound metabolic dysfunctions, compromised immune responses, and, in extreme cases, fatal outcomes. The systematic implementation of screening protocols—encompassing both anthropometric assessments and biochemical evaluations—plays a pivotal role in the early identification of malnutrition states. Concurrently, patient awareness and proactive behavior—specifically, the prompt seeking of specialized medical attention upon the emergence of initial symptoms such as unexplained weight loss, persistent fatigue, or cognitive impairments—are critical for halting disease progression and mitigating the risk of irreversible complications.